Celagenex

Celagenex is a biotechnology and pharmaceutical company dedicated to developing therapies for chronic lifestyle and degenerative diseases through the use of endogenous metabolites and nutrient signaling. The company's research focuses on achieving cellular and mitochondrial homeostasis by optimizing master metabolic switches such as Sirtuins, mTOR, and AMPK. Celagenex offers a diverse portfolio of commercial products in India targeting neurology, metabolic health, and hepatology, including treatments for diabetic neuropathy and stroke recovery. By leveraging a proprietary technology platform that combines biological metabolites with bioavailability enhancers, the company aims to reduce the global healthcare burden associated with mortality and morbidity from age-related diseases.